Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical TrialSaddam Al Demour, Abdalla Awidi, Ayman A. Zayed et al.|Urologia Internationalis|2018Cited by 109
Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton’s Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with Erectile Dysfunction: Phase 1/2 Clinical TrialSaddam Al Demour, Abdalla Awidi, Sofia Adwan et al.|Urologia Internationalis|2021Cited by 38
Perilesional injections of human platelet lysate versus platelet poor plasma for the treatment of diabetic foot ulcers: A <scp>double‐blinded</scp> prospective clinical trialHussam Alhawari, Abdalla Awidi, Hanan Jafar et al.|International Wound Journal|2023Cited by 23
Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase I/II safety and efficacy trialHanan Jafar, Abdalla Awidi, Rami Almousa et al.|Stem Cell Research & Therapy|2025Cited by 7
Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trialSaddam Al Demour, Abdalla Awidi, Sofia Adwan et al.|Basic and Clinical Andrology|2024Cited by 3